Form 4: ARS Pharmaceuticals Executive Receives Stock Grant
Insider Transaction (Form 4)
Margaret Ekins Smith, Chief Commercial Officer of ARS Pharmaceuticals, Inc., received 1,001,738 shares of common stock on September 1, 2026.
Summary
- Grant/award: acquired 1,001,738 Stock Option (right to buy) on September 1, 2026; holds 1,001,738 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Margaret Ekins Smith — Officer (Chief Commercial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Grant/award | Stock Option (right to buy) | 1,001,738 | — | — | 1,001,738 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Grant/award (1,001,738 shares) |
Keywords
insider transaction, Form 4, SPRY, ARS Pharmaceuticals, Inc., neutral, Margaret Ekins Smith
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.